BioSpace News Archive

Pliant Therapeutics, Inc. announced that Bernard Coulie, M.D., Ph.D., president and chief executive officer, will present an update on the company and its programs at two upcoming healthcare investor conferences.

From February 23 to March 17, six ISAE-SUPAERO students will fly to the Mars Desert Research Station (MDRS), located in the Utah desert.

Get your heart rate up and keep your joints healthy – all at the same time!

Cerus Corporation (Nasdaq:CERS) announced today that its fourth quarter and full-year 2018 results will be released on Tuesday, February 26, 2019, after the close of the stock market.

Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of “Quality, Affordable Self-care Products™", today announced that it will release its fourth quarter and calendar year 2018 financial results on Wednesday, February 27, 2019. The Company will host a conference call beginning at 4:30 p.m. (EST).

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiaries HempMeds® and Kannaway® announced today that HempMeds® Real Scientific Hemp Oil™ (RSHO™) Gold Label and Kannaway® Pure Gold hemp-derived cannabidiol (CBD) products have become the first two hemp-derived CBD dietary supplements to be listed in the Prescribers’ Digital Reference® (also known as Physicians’ Desk Reference or PDR).

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, and its private, wholly-owned subsidiary Centurion BioPharma Corporation, today announced the publication of peer reviewed, scientific research for LADR-7 (AE-Keto-Sulf07), one of its lead LADR™ (Linker Activated Drug Release) candidates.

Each system will be featured at the upcoming American College of Foot & Ankle Surgeons Conference.

iQMR will allow KAME, an affiliate of the Chinese medical conglomerate Beijing Century Galaxy Technology Group, to significantly increase its imaging capacity and productivity.

Breast implant removal is the highest-rated surgical treatment, with a 99% Worth It Rating